Stock A323990 VAXCELL-BIO THERAPEUTICS CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Highlights Vaxcell-Bio Therapeutics Co., Ltd.

Equities

A323990

KR7323990002

End-of-day quote Korea S.E.
Other stock markets
 03:30:00 19/06/2024 am IST 		5-day change 1st Jan Change
16,000 KRW -0.56% Intraday chart for Vaxcell-Bio Therapeutics Co., Ltd. -1.23% -28.73%
2023 Vaxcell-Bio Therapeutics Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
2021 Vaxcell-Bio Therapeutics Co., Ltd.(KOSDAQ:A323990) added to S&P Global BMI Index CI

Highlights

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Vaxcell-Bio Therapeutics Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
Vaxcell-Bio Therapeutics Co., Ltd. has completed an IPO in the amount of KRW 29.5548 billion.
CI
Vaxcell-Bio Therapeutics Co., Ltd. has filed an IPO.
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. A323990 Stock
  4. News Vaxcell-Bio Therapeutics Co., Ltd.
  5. Highlights